Sunday, December 30, 2012 Saturday, December 29, 2012 Friday, December 28, 2012- FDA Clears Anticlotting Drug Eliquisat Motley Fool (Fri, Dec 28)
- Viagra vs. Cialis: Little Blue Pill Is Losing Bigat Bloomberg (Fri, Dec 28)
- FDA clears anticlotting drug EliquisAP (Fri, Dec 28)
- Bristol-Myers Squibb and Pfizer Announce U.S. FDA Approval of ELIQUIS® (apixaban)Business Wire (Fri, Dec 28)
- Pfizer, Bristol-Myers Blood Thinner Approved by U.S. FDAat Bloomberg (Fri, Dec 28)
- Eliquis Cannot Alter Patent and Demographic Losses for Pfizerat Motley Fool (Fri, Dec 28)
- Can This Company Cure an Investor’s Portfolio?at Motley Fool (Fri, Dec 28)
- Dogs of the Dow: All Bark and No Bite in 2012at Motley Fool (Fri, Dec 28)
- A Look Back At The Year In Pharmaceuticalsat Investopedia (Fri, Dec 28)
- Pfizer Playing the Right Card Amid Changing Sector Landscapeat Motley Fool (Fri, Dec 28)
- Tivozanib And AVEO: Valuation Suggests Upside Ahead Of FDA Decisionat Seeking Alpha (Fri, Dec 28)
- Merck Reveals Side Effects From Niacin Studyat Forbes (Fri, Dec 28)
- Does Lilly's Pipeline Make the Grade?at Motley Fool (Fri, Dec 28)
- Fiscal Cliff Resistant Biotech Portfolio Strategy: New Molecular Diagnostics Based Oncology Therapies in the PipelineWall Street Transcript (Fri, Dec 28)
- Bayer Submits Regorafenib in JapanZacks (Fri, Dec 28)
- What Is Holding Back Teva from Rising?at Motley Fool (Fri, Dec 28)
- Idaho gets $2.9 million in drug company settlementAP (Fri, Dec 28)
- Pharma's High Risk, High Reward Bet Promoat Motley Fool (Fri, Dec 28)
- AbbVie Wants To Be Hunter, Not Hunted Post-Abbott Splitat Forbes (Fri, Dec 28)
- Do the Interactions of Pharma With Medical Experts Compromise Health Guidelines?at Forbes (Fri, Dec 28)
- The Dogs of the Dow Fall Behindat Wall St. Cheat Sheet (Fri, Dec 28)
Thursday, December 27, 2012Add PFE News to My Yahoo!   | |
|
0.07(0.24%) May 24, 4:00PM EDT|After Hours
:
29.02